Goldman Sachs’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $495K | Sell |
|
|||||
|
2025
Q1 | $1.36M | Sell |
|
|||||
|
2024
Q4 | $2.25M | Buy |
|
|||||
|
2024
Q3 | $915K | Sell |
|
|||||
|
2024
Q2 | $741K | Buy |
|
|||||
|
2024
Q1 | $1.3M | Buy |
|
|||||
|
2023
Q4 | $381K | Buy |
|
|||||
|
2023
Q3 | $329K | Sell |
|
|||||
|
2023
Q2 | $556K | Sell |
|
|||||
|
2023
Q1 | $1.07M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $87K | Sell |
|
|||||
|
2022
Q1 | $212K | Sell |
|
|||||
|
2021
Q4 | $978K | Buy |
|
|||||
|
2021
Q3 | $185K | Sell |
|
|||||
|
2021
Q2 | $2.98M | Buy |
|
|||||
|
2021
Q1 | $1.95M | Buy |
|